Evidence map›Paper›PMID 36733416›Full record

ArticleFrontiers in psychiatry2022

The applicability and efficacy of

Wenqing Zhao, Shuangyi Chen, Jun Hu, Qing Zhou, Jing Tao, Rui Gao, Jie Zhang, Shanshan Su, Yuan Wang, Yousong Su and 7 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wenqing ZhaoShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shuangyi ChenShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jun HuShanghai Xuhui Mental Health Center, Shanghai, China.
Qing ZhouShanghai Xuhui Mental Health Center, Shanghai, China.
Jing TaoShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rui GaoShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jie ZhangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanshan SuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yuan WangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yousong SuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yihua PengShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanru WuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qing FanShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Weibo ZhangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wenhui JiangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jun CaiShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jianyin QiuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mental health is a global issue requiring global attention. Depression and anxiety are two of the most common mental disorders (CMDs) and are characterized by high incidence and high comorbidity. In recent years, the prolonged COVID-19 pandemic and exacerbated social instability have posed significant challenges to the mental resilience and mental health outcomes of the global population. Now more than ever, with an increase in mental health needs, it has become even more crucial to find an effective solution to provide universal mental healthcare. Psychotherapy is of vital importance for those coping with symptoms of depression and anxiety and is used to enhance mental resilience. However, such therapy can be difficult to access in reality. In this context, the Objectives: As an online self-help platform for psychological intervention, the Methods: In this parallel-group, randomized controlled trial, a total of 200 mild to moderately depressed and/or anxious adults seeking self-help will be randomly recruited and assigned to either the micro-video psychological intervention group or the wait list control group. Online measurements by self-assessment will be taken at baseline, post-intervention, 1-month, and 3-month follow-up. Results: The primary results will involve symptoms of depression and anxiety. The secondary results will involve mental resilience. An analysis will be conducted based on the intention-to-treat principle. Discussion: This trial will examine whether the Clinical trial registration: http://www.chictr.org.cn/, identifier ChiCTR2100043725.

Indexed as

depression and anxiety symptomsmental resilienceprotocolpsychological interventionrandomized controlled trial (RCT)self-service

Identifiers

PMID36733416
PMCPMC9887015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.